Bowel preparation
Conditions
Interventions
Experimental group:intake sodium picosulfate/magnesium citrate
Control group:intake 3-L PEG-ELS
Sponsors
Shenzhen Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Chinese male or female patients aged between 18 and 75 years; 2. Patients voluntarily signed the informed consent and were orally informed of the specific test protocol; 3. The patient was diagnosed with IBD (remission, mild to moderate activity), including UC and CD, and was preparing for colonoscopy; 4. Patients are willing to follow the study instructions and have the ability to complete the entire study procedure.
Exclusion criteria
Exclusion criteria: 1. Female patients are pregnant or breast-feeding; 2. People who are allergic to any of the ingredients of the study drug; 3. Congestive heart failure or uncontrolled hypertension; 4. Gastrointestinal diseases that cause abdominal pain, nausea, and vomiting (gastric retention, active ulcers, outlet obstruction, gastroparesis or intestinal obstruction); 5. Toxic colitis; 6. Toxic megacolon; 7. History of emergency abdominal surgery such as acute appendicitis; 8. Comfirmed or suspected gastrointestinal obstruction or perforation; 9. Severe dehydration; 10. Rhabdomyolysis; 11. Hypermagnesia; 12. Severe impairment of renal function (creatinine clearance rate less than 30 mL/min); 13. Participated in other clinical trials within 3 months; 14. People without legal capacity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bowel preparation cleaness; | — |
Secondary
| Measure | Time frame |
|---|---|
| patients' acceptability of study drugs;patients' tolerability of study drugs;security; | — |
Countries
China
Contacts
Public ContactWei Gong
Shenzhen Hospital of Southern Medical University
Outcome results
None listed